BNTC: Benitec Biopharma Inc Net Sales Margin

Brandmark of Benitec (BNTC)

Benitec Biopharma Inc. holds an extensive patent portfolio for liver therapies, ensuring long-term revenue. Development efficiency is supported by external certified partners, which reduces the burden on internal laboratories. The core business net margin reflects the result of this synergy, where 0.00 represents the latest metric reading. A diversified portfolio of programs for treating rare eye pathologies minimizes the overall financial risks of the business.

Benitec Biopharma Inc. (BNTC) - Net Sales Margin from 07/04/2022 to 11/19/2026

Analytical breakdowns and data insights for company Benitec (BNTC)

- market value and analyst target forecast:
Initial company analysis:Benitec Biopharma, BNTC
Manufactured product of Benitec Biopharma Inc

Benitec Biopharma Inc. (BNTC) is facing a high operational cost base due to colossal R&D investments and stringent FDA oversight, which currently limits profitability. This indicator measures the portion of revenue converted into net income after all write-offs; therefore, sharp fluctuations in net profit margins signal abnormal shifts in cost structure or the capitalization efficiency of ddRNAi patents.

Who Benitec Biopharma Inc. competes with

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|IONS (Isis Pharmaceuticals) - Net Sales Margin|Repligen Inc. - Net Profit Margin|Net Sales Margin RNA|CRSP - Net Margin|GeneDx - Return on Sales by Net Profit|Net Profit Rate RARE|Beam Tx - Net Sales Margin|SRPT - Net Sales Margin|TWST (Twist Bio) - Return on Sales by Net Profit|Net Return on Sales TXG|Return on Sales by Net Profit NTLA|Stoke Therapeutics Inc (STOK) - Company Sales Margin|Net Sales Margin BLFS|Net Margin WVE (Wave Life Sciences Corp)|Net Margin Maze Therapeutics MAZE|Net Profit Rate SION|PRME - Net Margin|Company Sales Margin Taysha TSHA|QURE: Net Sales Margin|Return on Sales by Net Profit MeiraGTx PLC|RGNX (REGENXBIO Inc) - Net Sales Margin|solidbio.com (SLDB) - Company Sales Margin|Net Margin Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX